Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
University Hospital Tuebingen
West China Hospital
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
University of Nebraska